Guillain-Barré syndrome
 | This article is a stub. |
Guillain-Barré syndrome or GBS or acute inflammatory polyneuropathy or acute inflammatory demyelinating polyneuropathy or infectious polyneuritis is a rare neurological autoimmune disorder in which the body's immune system attacks part of the peripheral nervous system.[1][2]
Signs and symptoms
Initially:
Followed by:
- muscle weakness on both sides of the body which can increase in severity over a period of hours to weeks until the person is virtually paralyzed[1]
Treatment and prognosis
If breathing muscles are affected, the person is often put on a ventilator.
Most people make a good recovery from even the most severe cases of Guillain-Barré syndrome, although some people continue to have some degree of muscle weakness.[1]
See also
Learn more
- Guillain-Barré syndrome - WebMD
- Guillain-Barré syndrome - Johns Hopkins Medicine
- Guillain-Barré syndrome - CDC
- Guillain-Barré syndrome information - National Institute of Neurological Disorders and Stroke
- Guillain-Barré syndrome - Mayo clinic
- Guillain-Barré syndrome Information Sheet - National Institute of Neurological Disorders and Stroke
- Guillain-Barré syndrome - Genetic and Rare Diseases Information Center
References
- ↑ 1.01.11.2 "Guillain-Barré Syndrome Information Page". National Institute of Neurological Disorders and Stroke. Retrieved December 20, 2021.
- ↑ "Guillain-Barre syndrome". Genetic and Rare Diseases Information Center. Retrieved December 20, 2021.
Centers for Disease Control and Prevention (CDC) - The Centers for Disease Control and Prevention is a U.S. government agency dedicated to epidemiology and public health. It operates under the auspices of the Department of Health and Human Services.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
